TABLE 3.
Complications, stratified by tumor type
| Complication | Benign, N (%) | Malignant, N (%) | P value |
|---|---|---|---|
| Selective nerve branch sacrifice | 23 (3.5%) | 91 (33.8%) | <.0001 |
| Short‐term nerve weakness a | 34 (5.4%) | 19 (10.7%) | .006 |
| Long‐term nerve weakness a | 8 (1.3%) | 6 (3.4%) | .167 |
| Frey's syndrome | 12 (1.9%) | 2 (1.1%) | .193 |
a
Calculated only for patients without intentional selective nerve branch sacrifice intraoperatively and/or without preoperative facial nerve weakness, N = 632 for benign tumors, N = 178 for malignant tumors.
Bold denotes significant variables p < 0.05.